Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction
Top Cited Papers
- 29 June 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (25) , 3171-3175
- https://doi.org/10.1161/01.cir.0000130846.46168.03
Abstract
Background— Although clopidogrel reduces the risk of cardiovascular episodes after coronary events and stenting, a substantial number of incidents continue to occur.Keywords
This publication has 12 references indexed in Scilit:
- Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel ResistanceCirculation, 2004
- Clopidogrel for Coronary StentingCirculation, 2003
- Durability of platelet inhibition by clopidogrelThe American Journal of Cardiology, 2003
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002
- Individual variations of platelet inhibition after loading doses of clopidogrelJournal of Internal Medicine, 2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placementHeart, 2001
- Drug Interactions with Tobacco SmokingClinical Pharmacokinetics, 1999
- A NEW METHOD FOR QUANTITATIVE ANALYSIS OF WHOLE BLOOD PLATELET INTERACTION WITH EXTRACELLULAR MATRIX UNDER FLOW CONDITIONSThrombosis Research, 1997